| Compound |
Company |
Primary Therapeutical Area / Indication |
Drug development |
|
| NN1952 |
|
Nutritional and Metabolic Diseases / Diabetes Mellitus |
Phase I
|
 |
|
|
| NN9161 |
|
Nutritional and Metabolic Diseases / Obesity |
Phase I
|
 |
|
|
| NN9925 |
|
Nutritional and Metabolic Diseases / Diabetes Mellitus, Type 2 |
Phase I
|
 |
|
|
| PRC-4016 |
Pronova Biopharma Denmark
|
Nutritional and Metabolic Diseases / Dyslipidemias |
Phase I
|
 |
|
|
| SPC4955 |
|
Nutritional and Metabolic Diseases / Hypercholesterolemia |
Phase I
|
 |
|
|
| TM38837 |
|
Nutritional and Metabolic Diseases / Obesity |
Phase I
|
 |
|
|
| ZP2929 |
|
Nutritional and Metabolic Diseases / Diabetes Mellitus, Type 2 |
Phase I
|
 |
|
|
| 2hydroxyoleic acid |
Bridge BioResearch
|
Nutritional and Metabolic Diseases / Obesity |
Pre-clinical
|
 |
|
|
| CAM2036 |
|
Nutritional and Metabolic Diseases / Diabetes Mellitus, Type 2 |
Pre-clinical
|
 |
|
|
| Isosteviol |
Bridge BioResearch
|
Nutritional and Metabolic Diseases / Diabetes Mellitus, Type 2 |
Pre-clinical
|
 |
|
|
| Orph-001 |
Orphazyme
|
Nutritional and Metabolic Diseases / Lysosomal Storage Diseases |
Pre-clinical
|
 |
|
|
| PCSK9 |
|
Nutritional and Metabolic Diseases / Hyperlipidemias |
Pre-clinical
|
 |
|
|
| TransCon Hydrogel GLP-1 |
Ascendis Pharma A/S
|
Nutritional and Metabolic Diseases / Diabetes Mellitus, Type 2 |
Pre-clinical
|
 |
|
|
| TransCon Hydrogel Insulin/GLP-1 |
Ascendis Pharma A/S
|
Nutritional and Metabolic Diseases / Diabetes Mellitus, Type 2 |
Pre-clinical
|
 |
|
|
| Grazax |
|
Respiratory Tract (Lung and Bronchial) Diseases / Rhinitis, Allergic, Seasonal |
Phase IV
|
 |
|
|
| ALK HDM tablet |
|
Respiratory Tract (Lung and Bronchial) Diseases / Asthma |
Phase III
|
 |
|
|
| IodoCarb® |
PharmaLundensis AB
|
Respiratory Tract (Lung and Bronchial) Diseases / Pulmonary Disease, Chronic Obstructive |
Phase II
|
 |
|
|
| THR-B7 |
|
Respiratory Tract (Lung and Bronchial) Diseases / Pneumonia |
Phase II
|
 |
|
|
| RESP-1000 |
|
Respiratory Tract (Lung and Bronchial) Diseases / Pulmonary Disease, Chronic Obstructive |
Pre-clinical
|
 |
|
|
| Alefacept |
|
Skin and Connective Tissue Diseases / Psoriasis |
Phase IV
|
 |
|
|